SCHEMBL130343

SCHEMBL130343

Nc1ccc(C(=O)NCCC(=O)O)cc1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.68
MAPT P10636 1/20 0.68
HIF1A Q16665 1/20 0.68
SLC22A6 Q4U2R8 1/20 0.68
SLC22A8 Q8TCC7 1/20 0.68
CA1 P00915 3/20 0.66
CA2 P00918 3/20 0.66
MAPK1 P28482 2/20 0.61
HDAC3 O15379 2/20 0.58
HDAC4 P56524 2/20 0.58
HDAC1 Q13547 2/20 0.58
HDAC7 Q8WUI4 2/20 0.58
HDAC2 Q92769 2/20 0.58
HDAC10 Q969S8 2/20 0.58
HDAC11 Q96DB2 2/20 0.58
HDAC8 Q9BY41 2/20 0.58
HDAC6 Q9UBN7 2/20 0.58
HDAC9 Q9UKV0 2/20 0.58
HDAC5 Q9UQL6 2/20 0.58
LMNA P02545 3/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7924841 0.95 KDM4E (0.62) KDM4EMAPTHIF1ASLC22A6SLC22A8
Trifluoroacetic Acid SCHEMBL2650961 0.91 KDM4E (0.57) KDM4EMAPTHIF1ASLC22A6SLC22A8
SCHEMBL9717434 0.90 MAPK1 (0.71) KDM4EMAPTHIF1ASLC22A6SLC22A8
SCHEMBL6263089 0.89 MAPK1 (0.72) KDM4EMAPTHIF1ASLC22A6SLC22A8
SCHEMBL8435925 0.88 MAPK1 (0.81) KDM4EMAPTHIF1ASLC22A6SLC22A8
SCHEMBL6258138 0.86 MAPK1 (0.84) KDM4EMAPTHIF1ASLC22A6SLC22A8
SCHEMBL28757390 0.86 MAPK1 (0.84) KDM4EMAPTHIF1ASLC22A6SLC22A8
SCHEMBL9344489 0.86 KDM4E (0.68) KDM4EMAPTHIF1ASLC22A6SLC22A8
SCHEMBL13113134 0.84 LMNA (0.59) KDM4EMAPTHIF1ASLC22A6SLC22A8
SCHEMBL3211210 0.83 CA1 (0.63) MAPTHIF1ACA1CA2MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 222 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1720536-B1 USE OF AMINOSALICYLATES IN DIARRHOEA-PREDOMINENT IRRITABLE BOWEL SYNDROME PHARMATEL R & D PTY LTD AS TRUSTEE FOR THE PHARMATEL R & D TRUST (AU) 2012-04-25 EP claimed
US-7271253-B1 Safe process for the preparation of balsalazide APOTEX PHARMACHEM INC. (CA) 2007-09-18 US claimed
US-20060110743-A1 Drug evolution: drug design at hot spots KONISHI YASUO 2006-05-25 US claimed
WO-2002095393-A2 DRUG EVOLUTION: DRUG DESIGN AT HOT SPOTS NATIONAL RESEARCH COUNCIL OF CANADA (CA) 2002-11-28 WO claimed
US-5757408-A PRINTING IMAGE ON SUBSTRATE COATED WITH AMINO-ACID DERIVATIVE ADDITIVE; QUICK DRYING OF INK, OPTICAL DENSITY, NONCURLING XEROX CORPORATION (US) 1998-05-26 US claimed
US-5683793-A Ink jet transparencies XEROX CORPORATION (US) 1997-11-04 US claimed
US-5589277-A INK JET PRINTING, AQUEOUS INKS, FAST DRYING XEROX CORPORATION (US) 1996-12-31 US claimed
EP-0667246-A1 Recording sheets containing amino acids, hydroxy acids, and polycarboxyl compounds XEROX CORPORATION (US) 1995-08-16 EP claimed
CN-113970607-B Detection method of related substances in balsalazide sodium capsules 马应龙药业集团股份有限公司 2024-03-26 CN disclosed
EP-3762365-B1 METHODS AND COMPOSITIONS OF ISOINDOLINE-1,3-DIONE AND ISOINDOLE PRODRUGS USEFUL FOR TREATING CANCER, ULCERATIVE COLITIS AND RELATED INFLAMMATORY DISEASES AMGEN EUROPE GMBH (CH) 2024-02-21 EP disclosed
EP-3979991-B1 COLONIC RELEASE FOOD SUPPLY AS A COADJUVANT IN THE TREATMENT AND PREVENTION OF COLONIC DISORDERS CAUSED BY A SUSPECTED OR CONFIRMED ALTERATION OF THE INFLAMMATORY PATTERN AND MICROBIOTA DESTABILIZATION CRISTALFARMA S R L (IT) 2023-11-15 EP disclosed
WO-2023201044-A2 JAK INHIBITOR ANALOGS, FORMULATIONS, AND USES THEREOF THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2023-10-19 WO disclosed
EP-3450506-B1 THERMOPLASTIC ELASTOMER COMPOSITION, PRODUCTION METHOD THEREFOR, AND ELASTOMER MOLDED BODY JXTG NIPPON OIL & ENERGY CORP (JP) 2023-10-18 EP disclosed
CN-115536638-B Triazole compound and application thereof 上海交通大学 2023-10-13 CN disclosed
US-5354499-A Reaction products of lyotropic liquid crystal salt complexes ELLIOTT STANLEY B (US) 1994-10-11 US disclosed
US-5354496-A Lyotropic liquid crystal salt/inorganic compound complexation products ELLIOTT STANLEY B (US) 1994-10-11 US disclosed
US-5082588-A Hygrometers ELLIOTT STANLEY B (US) 1992-01-21 US disclosed
EP-0456093-A2 Biguanide derivatives and biocidal compositions containing them H.B. FULLER LICENSING & FINANCING, INC. (US) 1991-11-13 EP disclosed
US-4975249-A Optical and capacitance type, phase transition, humidity-responsive devices ELLIOTT STANLEY B (US) 1990-12-04 US disclosed
US-4412992-A 2-Hydroxy-5-phenylazobenzoic acid derivatives and method of treating ulcerative colitis therewith BIOREX LABORATORIES LIMITED (GB) 1983-11-01 US disclosed